{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:00:38Z","timestamp":1784228438356,"version":"3.55.0"},"reference-count":56,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100015938","name":"Hillman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015938","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medication for Opioid Use Disorder (MOUD) has been shown to be a safe, cost-effective intervention that successfully lowers risk of opioid overdose. However, access to and use of MOUD has been limited. Our objective was to explore attitudes, opinions, and beliefs regarding MOUD among healthcare and social service providers in a community highly impacted by the opioid overdose epidemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>As part of a larger ethnographic study examining neighborhoods in Allegheny County, PA, with the highest opioid overdose death rates, semi-structured qualitative in-person and telephone interviews were conducted with forty-five providers treating persons with opioid use disorders in these communities. An open coding approach was used to code interview transcripts followed by thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three major themes were identified related to MOUD from the perspectives of our provider participants. Within a variety of health and substance use service roles and settings, provider reflections revealed: (1) different opinions about MOUD as a transition to abstinence or as a long-term treatment; (2) perceived lack of uniformity and dissemination of accurate information of MOUD care, permitting differences in care, and (3) observed barriers to entry and navigation of MOUD, including referrals as a \u201cword-of-mouth insider system\u201d and challenges of getting patients MOUD services when they need it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Even in communities hard hit by the opioid overdose epidemic, healthcare providers\u2019 disagreement about the standard of care for MOUD can be a relevant obstacle. These insights can inform efforts to improve MOUD treatment and access for people with opioid use disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2021.2007518","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T16:14:55Z","timestamp":1643645695000},"page":"742-748","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Provider Perceptions of Medication for Opioid Used Disorder (MOUD): A Qualitative Study in Communities with High Opioid Overdose Death Rates"],"prefix":"10.1177","volume":"43","author":[{"given":"Nicole","family":"Paul","sequence":"first","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Washington School of Medicine, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Taubenberger","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Chang","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hacker","sequence":"additional","affiliation":[{"name":"Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2021.2007518","unstructured":"Centers for Disease Control and Prevention. Understanding the epidemic; 2020. https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html. Accessed January 10, 2020."},{"key":"bibr2-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.7326\/L18-0685"},{"issue":"2","key":"bibr3-08897077.2021.2007518","first-page":"CD002207","author":"Mattick RP","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr4-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1610830"},{"key":"bibr5-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60358-9"},{"key":"bibr6-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1111\/add.14180"},{"key":"bibr7-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.06.001"},{"key":"bibr8-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33078-2"},{"key":"bibr9-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1735"},{"key":"bibr10-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05162"},{"key":"bibr11-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05944-6"},{"key":"bibr12-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105785"},{"key":"bibr13-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-020-09706-4"},{"key":"bibr14-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-1047-z"},{"key":"bibr15-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1325376"},{"key":"bibr16-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.04.039"},{"key":"bibr17-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1878084"},{"key":"bibr18-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1891601"},{"key":"bibr19-08897077.2021.2007518","unstructured":"Allegheny County Department of Human Services. Opioid-related overdose deaths in Allegheny County: Report and maps; 2018. https:\/\/www.alleghenycountyanalytics.us\/index.php\/2018\/02\/15\/opioid-related-overdose-deaths-allegheny-county-report-data-visualizations\/. Accessed August 5, 2020."},{"key":"bibr20-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1177\/0096144214551730"},{"key":"bibr21-08897077.2021.2007518","unstructured":"U.S. General Services Administration. Allegheny County hospitals; 2018. https:\/\/catalog.data.gov\/dataset\/allegheny-county-hospitals. Accessed July 12, 2020."},{"key":"bibr22-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2004.02.028"},{"key":"bibr23-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2003.035899"},{"key":"bibr24-08897077.2021.2007518","volume-title":"Qualitative research evaluation methods.","author":"Patton MQ.","year":"2002","edition":"3"},{"key":"bibr25-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1177\/1098214005283748"},{"issue":"2","key":"bibr26-08897077.2021.2007518","first-page":"108","volume":"15","author":"Glaser BG.","year":"2016","journal-title":"Grounded Theory Review"},{"key":"bibr27-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X19838237"},{"key":"bibr28-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1111\/nhs.12048"},{"key":"bibr29-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"bibr30-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1177\/002204267700700102"},{"key":"bibr31-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201600056"},{"issue":"5","key":"bibr32-08897077.2021.2007518","first-page":"588","volume":"152","author":"Zweben JE","year":"1990","journal-title":"West J Med"},{"key":"bibr33-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1402780"},{"key":"bibr34-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.3109\/10826088509047261"},{"key":"bibr35-08897077.2021.2007518","unstructured":"Centers for Disease Control and Prevention. Opioid overdose: guides and meeting reports; 2019. https:\/\/www.cdc.gov\/drugoverdose\/pubs\/guides-meeting-reports.html. Accessed November 17, 2020."},{"key":"bibr36-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1652"},{"key":"bibr37-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.12.011"},{"key":"bibr38-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5302"},{"key":"bibr39-08897077.2021.2007518","unstructured":"Substance Abuse and Mental Health Services Administration. TIP 63: medications for opioid use disorder; 2018. https:\/\/store.samhsa.gov\/product\/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document\/PEP21-02-01-002. Accessed September 14, 2020."},{"key":"bibr40-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108027"},{"key":"bibr41-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.04.005"},{"key":"bibr42-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12454"},{"key":"bibr43-08897077.2021.2007518","volume-title":"Things under the tongue: pharmacotherapy, its intersections and its afterlife in urban America","author":"Meyers T."},{"key":"bibr44-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.05.010"},{"key":"bibr45-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20843"},{"key":"bibr46-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.10.004"},{"key":"bibr47-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107555"},{"key":"bibr48-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4721-x"},{"key":"bibr49-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.05.007"},{"key":"bibr50-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3474"},{"key":"bibr51-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2019.80.693"},{"key":"bibr52-08897077.2021.2007518","unstructured":"Substance Abuse and Mental Health Services Administration. Use of medication-assisted treatment in emergency departments; 2021. https:\/\/store.samhsa.gov\/sites\/default\/files\/SAMHSA_Digital_Download\/pep21-pl-guide-5.pdf. Accessed August 9, 2021."},{"key":"bibr53-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22154"},{"key":"bibr54-08897077.2021.2007518","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1752351"},{"key":"bibr55-08897077.2021.2007518","unstructured":"Substance Abuse and Mental Health Services Administration. FAQs: provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency; 2020. https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf. Accessed August 10, 2021."},{"key":"bibr56-08897077.2021.2007518","unstructured":"Allegheny County Department of Human Services. The journey into Allegheny County's substance use disorder treatment system: using human-centered design to learn more about people's experiences with entering treatment; 2018. https:\/\/www.alleghenycountyanalytics.us\/wp-content\/uploads\/2019\/01\/18-ACDHS-24_SubstanceUse_012219.pdf. Accessed August 5, 2020."}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.2007518","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.2007518","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.2007518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:56:06Z","timestamp":1777625766000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.2007518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2021.2007518"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.2007518","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}